elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q54986008-10AA5A54-EEED-40DA-BEB6-24C82BD11263
Q54986008-10AA5A54-EEED-40DA-BEB6-24C82BD11263
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54986008-10AA5A54-EEED-40DA-BEB6-24C82BD11263
Repurposing established cyclic adenosine monophosphate reducing agents for the prevention and therapy of epidermal growth factor receptor inhibitor resistance in non-small cell lung cancer.
P2860
Q54986008-10AA5A54-EEED-40DA-BEB6-24C82BD11263
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54986008-10AA5A54-EEED-40DA-BEB6-24C82BD11263
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c9c06fd16c152816c7b8ac421d0b85bf47097c93
P2860
Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.